trial

Prevalence of Dissociative Disorders in Children

NCTId NCT01512641
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 301 (actual)
Sponsored by Centre Hospitalier Universitaire de Nice
Primary completion 2013-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
301 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2011-12
Primary completion
2013-05
Eligibility
ALL · 7 Years · 18 Years

Interventions & indications

Drugs
Primary stageSecondary stage

Sponsors

Centre Hospitalier Universitaire de NiceLead Sponsor

Investigators

5
Florence ASKENAZY, PU-PHStudy Director
Emmanuelle DOR, PHPrincipal Investigator
François POINSO, PU-PHPrincipal Investigator
Michèle BATTISTA, PHPrincipal Investigator
Michel BOUBLIL, PHPrincipal Investigator

Sites

4 total
Antibes, FranceFréjus, FranceMarseille, FranceNice, France

Facts & assertions

4 sourced
Enrollment
301
Phase
NA
Primary Completion Date
2013-05
Status
COMPLETED
relationships
The graph out of here
drug
Primary stage
drug
Secondary stage
drug
lead_sponsor
Centre Hospitalier Universitaire de Nice
company
indication
Schizophrenia
indication
Schizophrenia
indication
Dissociative Disorders
indication
investigator
Florence ASKENAZY, PU-PH
person
Emmanuelle DOR, PH
person
François POINSO, PU-PH
person
Michèle BATTISTA, PH
person